David Maloney

MD, PhD
Fred Hutchinson Cancer Research Center

David Maloney, MD, PhD, is a board certified physician at Seattle Cancer Care Alliance (SCCA), a member in the Clinical Research Division at Fred Hutchinson Cancer Research Center and a University of Washington professor of Medicine and Oncology.

Dr Maloney earned his MD and PhD at Stanford, and is the SCCA lead investigator for the following clinical trials: Autologous Stem Cell Transplant Followed By Donor Stem Cell Transplant In Treating Patients With Relapsed or Refractory Lymphoma, Ofatumumab vs. Rituximab for Relapsed Follicular Lymphoma and Immunotherapy for Advanced CD19+ Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma.

Dr Maloney applies the latest research on new treatments when treating his patients for chronic lymphocytic leukemia, non-Hodgkin’s lymphoma and multiple myeloma, and is focused on the development of new, safe and effective therapies. His clinical expertise is with antibodies, vaccines, and bone marrow transplantation for the treatment of these malignancies.